The interface genes in the IBT_Her2+_TNBC module were enriched in IBD and hepatitis B signaling pathways, suggesting that inflammatory breast tissues might also contain similar factors and mechanisms that promote the inflammation-cancer transformation (Figure 3B). This evidence concerns the gene ERBB2 and hepatitis B virus infection.